PPH
VanEck Pharmaceutical ETFstockNASDAQETF
The investment seeks to replicate as closely as possible, before fees and expenses, the price and yield performance of the MVIS® US Listed Pharmaceutical 25 Index. The fund normally invests at least 80% of its total assets in securities that comprise the fund's benchmark index. The index includes common stocks and depositary receipts of U.S. exchange-listed companies in the pharmaceutical sector. Such companies may include medium-capitalization companies and foreign companies that are listed on a U.S. exchange. It is non-diversified.
| Period | Price | Date | Change | Beta |
|---|---|---|---|---|
| 1W | 121.30 | 2026-11-12 | -2.79% | 0.309 |
| 1M | 113.48 | 2026-10-19 | +3.90% | 0.490 |
| 3M | 117.28 | 2026-08-19 | +0.54% | 0.412 |
| 6M | 102.46 | 2026-05-19 | +15.08% | 0.086 |
| 1Y | 99.10 | 2025-11-19 | +18.98% | 0.303 |
| 2Y | 86.87 | 2024-11-19 | +35.73% | — |
| 5Y | 74.40 | 2021-11-19 | +58.48% | 0.449 |
VanEck Pharmaceutical ETF (NASDAQ:PPH) stock price today is $117.91, and today's volume is 294,151. PPH is down 1.815% today. The 30 day average volume is 382,078. PPH market cap is $1.05B with 8.94M shares outstanding.